AHP Medicines 
Project 
Helen Marriott 
AHP Medicines Project Lead 
November 2014 
www.england.nhs.uk
Introduction 
• Prescribing and medicines supply mechanisms 
• Supply and administration of medicines 
• Patient Specific Directions (PSD) 
• Patient Group Directions (PGD) 
• Exemptions (from the Medicines Act) 
• Non-medical prescribing 
• Supplementary prescribing 
• Independent prescribing 
www.england.nhs.uk
Supply and administration mechanisms 
Mechanism Summary Additional notes 
A Patient Specific Direction is a doctor's (normally 
written) instruction that enables a person to supply or 
administer a medicine to a named patient. 
www.england.nhs.uk 
Useful in both primary care and 
secondary care. 
Wide-reaching (can encompass 
controlled drugs (CDs)). 
Relies on input of doctor. 
A Patient Group Direction is a written instruction for 
the supply and/or administration of a licensed 
medicine to a patient or group of patients, where the 
patient may not be individually identified. It must be 
agreed/signed by a doctor and senior pharmacist, and 
approved by the employer. It authorises named 
registered health professional(s) to supply/administer 
a licensed medicine. 
Useful in many settings in primary 
care and secondary care. 
Can be slow to set up. 
Does not allow mixing of medicines. 
CDs: Schedules 4 and 5 may be 
included. Midazolam (now schedule 
3) can also be included. 
An Exemption (to medicines legislation) allows the 
sale, supply and administration of specific drugs in 
specific circumstances. 
Useful in some settings. 
Used by podiatrists, paramedics, 
optometrists and midwives. 
Inflexible - only for named 
medicines.
Mechanism Summary Additional notes 
Supplementary Prescribing is a 
partnership with an independent prescriber 
(doctor) for a named patient, via an agreed 
patient-specific, clinical management plan. 
The supplementary prescriber can alter 
dosage, and remove or write prescriptions 
according to that plan. 
www.england.nhs.uk 
Useful in some settings in primary 
care and secondary care. 
Original guidance stated: 
'Intended use mainly for long-term 
conditions and continuing care'. 
Dependent on link to and agreement 
of doctor. 
Independent Prescribing involves taking full 
responsibility for prescribing decisions and 
autonomously writing prescriptions. 
Most flexible and responsive 
mechanism. 
Involves full responsibility for 
independent assessment, diagnosis 
and prescribing. 
Limitations on CDs. 
Prescribing mechanisms
Current mechanisms available to AHPs 
Allied health 
profession 
www.england.nhs.uk 
Patient 
Specific 
Directions 
Patient 
Group 
Directions 
Exemptions Supplementary 
Prescribing 
Independent 
Prescribing 
Physiotherapists 2000 2005 2013 
Podiatrists 2000 
1980, 1998 
Revised 2006 
2005 2013 
Radiographers 2000 2005 
Dietitians 2003 
Speech and 
language 
2003 
therapists 
Occupational 
therapists 
2003 
Orthoptists 2003 
Paramedics 2000 
1992 
Revised 1998, 
2000, 2004 
Prosthetists and 
orthotists 
2003 
Art therapists 
Music therapists 
Dramatherapists
The AHP Medicines Project 
• In 2009 the Department of Health commissioned the Allied 
Health Professions Prescribing & Medicines Supply Mechanisms 
Scoping Project Report 
Phase 1 
• Independent prescribing for 
physiotherapists and podiatrists 
• The amendments to legislation 
were laid in the summer of 2013 
www.england.nhs.uk
August 
2013 
www.england.nhs.uk 
May 
2014 
September 
2014 
October 
2014 
Devolved administrations 
England 
Scotland 
Wales 
Northern 
Ireland
AHP medicines project - Phase 2 
• Jointly funded initiative by NHS England and the Department of 
Health 
• The project team has been in place since October 2013 
• The current proposals: 
• Independent prescribing by paramedics 
• Independent prescribing by radiographers 
• Supplementary prescribing by dietitians 
• Use of exemptions by orthoptists 
www.england.nhs.uk
www.england.nhs.uk 
Helen Marriott 
Project Lead 
George Hilton 
Project 
Administrator 
Steven Sims 
Project Support 
Officer 
Hannah-Rose 
Douglas 
Analyst 
X4 
Professional 
Body Project 
Officers 
AHP Medicines Project Team
Process 
Preliminary work to identify the case of need 
Development of statutory public 
consultation 
Public consultation 
Commission on human medicines (CHM) 
Changes to legislation 
www.england.nhs.uk 
Evaluation 
•Aligned with 
NHSE objectives 
& priorities 
•Approved by 
NMP board
Case of need - Benefits 
Patient safety 
• Clearer lines of responsibility 
• Reducing onward referral and 
admissions and their associated risks 
• Reducing risks and costs associated 
with delays in care 
• Medicines optimisation 
Patient experience 
• Reducing inconvenience of multiple 
appointments 
• Support to self-care as close to home as 
possible 
• Enable service re-design to improve 
access to services 
www.england.nhs.uk 
Clinical effectiveness 
• Provision of best care, first time, in the 
right place 
• Reduce long-term condition episodes 
requiring admission 
• Improved health and well-being 
Value for money 
• Effective use of resources 
• Supports service re-design 
• More flexible, responsive and 
empowered workforce
Case of need – Approval Process 
• Case of need approved by: 
NHS England SMTs 
www.england.nhs.uk 
NMP board 
Ministerial approval 
to commence 
preparation for 
public consultation 
June 2014 
August 2014 
July 2014
Project Board 
• Oversee the governance of the project 
whilst providing support and guidance 
to the programme of work 
• Co-chaired by: 
Suzanne Rastrick (CAHPO) 
Bruce Warner (Deputy Chief 
Pharmaceutical Officer 
• Meet monthly basis 
www.england.nhs.uk
Next steps… 
On going 
Prepare 
online 
consultation & 
supporting 
documents 
October – December 2014 
Stakeholder 
Engagement 
www.england.nhs.uk 
November 2014 
Commission 
on Human 
Medicines 
Late 2014 
Seek 
approval to 
publish public 
consultation 
- NHSE 
- NMP board 
- Ministers 
Early 2015 
Publish public 
consultations
Consultation Documents 
• Four separate online consultations 
Supporting documentation 
• Draft impact assessment for each proposal 
• Draft practice guidance for each profession 
• Draft outline curriculum framework for independent and supplementary 
prescribing education and training programmes (Paramedics, 
Radiographers, Dietitians) 
• Draft outline curriculum framework for conversion programmes to 
prepare radiographer supplementary prescribers as independent 
prescribers (Radiographers) 
• Draft outline curriculum framework for education and training 
programmes for the use of exemptions by orthoptists (Orthoptists) 
www.england.nhs.uk
Your help…. 
1) Managing stakeholder expectations 
2) Think about implementation NOW! 
3) Identifying where IP by physio’s and podiatrists will 
improve quality of patient care and service delivery 
www.england.nhs.uk
Thank you 
www.england.nhs.uk 
Email: h.marriott@nhs.net 
Twitter: @marriotthelen

Prescribing, administration and supply of medicines by allied health professionals

  • 1.
    AHP Medicines Project Helen Marriott AHP Medicines Project Lead November 2014 www.england.nhs.uk
  • 2.
    Introduction • Prescribingand medicines supply mechanisms • Supply and administration of medicines • Patient Specific Directions (PSD) • Patient Group Directions (PGD) • Exemptions (from the Medicines Act) • Non-medical prescribing • Supplementary prescribing • Independent prescribing www.england.nhs.uk
  • 3.
    Supply and administrationmechanisms Mechanism Summary Additional notes A Patient Specific Direction is a doctor's (normally written) instruction that enables a person to supply or administer a medicine to a named patient. www.england.nhs.uk Useful in both primary care and secondary care. Wide-reaching (can encompass controlled drugs (CDs)). Relies on input of doctor. A Patient Group Direction is a written instruction for the supply and/or administration of a licensed medicine to a patient or group of patients, where the patient may not be individually identified. It must be agreed/signed by a doctor and senior pharmacist, and approved by the employer. It authorises named registered health professional(s) to supply/administer a licensed medicine. Useful in many settings in primary care and secondary care. Can be slow to set up. Does not allow mixing of medicines. CDs: Schedules 4 and 5 may be included. Midazolam (now schedule 3) can also be included. An Exemption (to medicines legislation) allows the sale, supply and administration of specific drugs in specific circumstances. Useful in some settings. Used by podiatrists, paramedics, optometrists and midwives. Inflexible - only for named medicines.
  • 4.
    Mechanism Summary Additionalnotes Supplementary Prescribing is a partnership with an independent prescriber (doctor) for a named patient, via an agreed patient-specific, clinical management plan. The supplementary prescriber can alter dosage, and remove or write prescriptions according to that plan. www.england.nhs.uk Useful in some settings in primary care and secondary care. Original guidance stated: 'Intended use mainly for long-term conditions and continuing care'. Dependent on link to and agreement of doctor. Independent Prescribing involves taking full responsibility for prescribing decisions and autonomously writing prescriptions. Most flexible and responsive mechanism. Involves full responsibility for independent assessment, diagnosis and prescribing. Limitations on CDs. Prescribing mechanisms
  • 5.
    Current mechanisms availableto AHPs Allied health profession www.england.nhs.uk Patient Specific Directions Patient Group Directions Exemptions Supplementary Prescribing Independent Prescribing Physiotherapists 2000 2005 2013 Podiatrists 2000 1980, 1998 Revised 2006 2005 2013 Radiographers 2000 2005 Dietitians 2003 Speech and language 2003 therapists Occupational therapists 2003 Orthoptists 2003 Paramedics 2000 1992 Revised 1998, 2000, 2004 Prosthetists and orthotists 2003 Art therapists Music therapists Dramatherapists
  • 6.
    The AHP MedicinesProject • In 2009 the Department of Health commissioned the Allied Health Professions Prescribing & Medicines Supply Mechanisms Scoping Project Report Phase 1 • Independent prescribing for physiotherapists and podiatrists • The amendments to legislation were laid in the summer of 2013 www.england.nhs.uk
  • 7.
    August 2013 www.england.nhs.uk May 2014 September 2014 October 2014 Devolved administrations England Scotland Wales Northern Ireland
  • 8.
    AHP medicines project- Phase 2 • Jointly funded initiative by NHS England and the Department of Health • The project team has been in place since October 2013 • The current proposals: • Independent prescribing by paramedics • Independent prescribing by radiographers • Supplementary prescribing by dietitians • Use of exemptions by orthoptists www.england.nhs.uk
  • 9.
    www.england.nhs.uk Helen Marriott Project Lead George Hilton Project Administrator Steven Sims Project Support Officer Hannah-Rose Douglas Analyst X4 Professional Body Project Officers AHP Medicines Project Team
  • 10.
    Process Preliminary workto identify the case of need Development of statutory public consultation Public consultation Commission on human medicines (CHM) Changes to legislation www.england.nhs.uk Evaluation •Aligned with NHSE objectives & priorities •Approved by NMP board
  • 11.
    Case of need- Benefits Patient safety • Clearer lines of responsibility • Reducing onward referral and admissions and their associated risks • Reducing risks and costs associated with delays in care • Medicines optimisation Patient experience • Reducing inconvenience of multiple appointments • Support to self-care as close to home as possible • Enable service re-design to improve access to services www.england.nhs.uk Clinical effectiveness • Provision of best care, first time, in the right place • Reduce long-term condition episodes requiring admission • Improved health and well-being Value for money • Effective use of resources • Supports service re-design • More flexible, responsive and empowered workforce
  • 12.
    Case of need– Approval Process • Case of need approved by: NHS England SMTs www.england.nhs.uk NMP board Ministerial approval to commence preparation for public consultation June 2014 August 2014 July 2014
  • 13.
    Project Board •Oversee the governance of the project whilst providing support and guidance to the programme of work • Co-chaired by: Suzanne Rastrick (CAHPO) Bruce Warner (Deputy Chief Pharmaceutical Officer • Meet monthly basis www.england.nhs.uk
  • 14.
    Next steps… Ongoing Prepare online consultation & supporting documents October – December 2014 Stakeholder Engagement www.england.nhs.uk November 2014 Commission on Human Medicines Late 2014 Seek approval to publish public consultation - NHSE - NMP board - Ministers Early 2015 Publish public consultations
  • 15.
    Consultation Documents •Four separate online consultations Supporting documentation • Draft impact assessment for each proposal • Draft practice guidance for each profession • Draft outline curriculum framework for independent and supplementary prescribing education and training programmes (Paramedics, Radiographers, Dietitians) • Draft outline curriculum framework for conversion programmes to prepare radiographer supplementary prescribers as independent prescribers (Radiographers) • Draft outline curriculum framework for education and training programmes for the use of exemptions by orthoptists (Orthoptists) www.england.nhs.uk
  • 16.
    Your help…. 1)Managing stakeholder expectations 2) Think about implementation NOW! 3) Identifying where IP by physio’s and podiatrists will improve quality of patient care and service delivery www.england.nhs.uk
  • 17.
    Thank you www.england.nhs.uk Email: [email protected] Twitter: @marriotthelen